Aller au contenu
Sommeil et rythmesÉtude transversale3 min read

Less nighttime sleep is linked to more early brain amyloid in older adults without impairment

Collectif éditorial MoveVitals · Study published · Reading updated

Original paper:Association of Sleep and β-Amyloid Pathology Among Older Cognitively Unimpaired Adults. · JAMA network open · 2021 · Article original ↗

À retenir

Among 4425 cognitively unimpaired adults aged 65 to 85, each additional hour of self-reported nighttime sleep was associated with a 0.005 lower global β-amyloid standardized uptake value ratio (P = .03), while daytime sleep was linked to higher amyloid in some regions. The effects are small and cross-sectional, so they cannot show that sleep changes amyloid rather than the reverse.

Study design

Étude transversale

Reading basis

Published abstract

Reading focus

Association & confounding

Cette explication éditoriale existe en anglais, chinois simplifié et chinois traditionnel. Cette interface affiche la lecture en anglais.

Question de recherche

Sleep often becomes disrupted as neurodegenerative disease progresses, but it is unclear how large the link is and when it starts, before any cognitive impairment. The authors tested how daytime and nighttime sleep duration relate to regional β-amyloid, a hallmark protein of early Alzheimer disease, in older adults.

Population et méthode

Cross-sectional analysis of screening data collected between April 1, 2014 and December 31, 2017 for the Anti-Amyloid Treatment in Asymptomatic Alzheimer Disease (A4) Study. Participants were healthy adults aged 65 to 85 with florbetapir F 18 PET, APOE genotype, a Mini-Mental State Examination score of 25 to 30 and a Clinical Dementia Rating of 0. The exposures were self-reported daytime and nighttime sleep duration, and the outcome was regional β-amyloid on PET (standardized uptake value ratio). Data were analysed from December 1, 2019 to May 10, 2021.

Résultats

The authors’ reported results. Read each estimate with its population and uncertainty.

  1. 1
    The 4425 participants had a mean (SD) age of 71.3 (4.7) years; 2628 (59.4%) were female and 1509 (34.1%) tested β-amyloid positive.
  2. 2
    Each additional hour of nighttime sleep was associated with lower amyloid: 0.005 lower global (P = .03), 0.009 lower in the medial orbitofrontal region (P < .001) and 0.011 lower in the anterior cingulate (P < .001).
  3. 3
    Among amyloid-negative participants, an extra hour of nighttime sleep was associated with 0.006 lower medial orbitofrontal amyloid (P < .001) and 0.005 lower anterior cingulate amyloid (P = .03).
  4. 4
    In amyloid-negative participants, daytime sleep was associated with higher amyloid: 0.013 higher in the precuneus (P = .03) and 0.024 higher in the posterior cingulate (P = .001). The authors say daytime sleep did not appear to make up for lost nighttime sleep.

Limites et incertitude

  1. 1
    Sleep duration was self-reported, which is less accurate than measured sleep.
  2. 2
    Cross-sectional data capture one time point, so they cannot show whether short sleep leads to amyloid buildup or early amyloid disrupts sleep.
  3. 3
    The differences are small (a few thousandths of a ratio unit per hour), and the abstract does not give confidence intervals or say how much they matter clinically.
  4. 4
    The A4 screening sample is selected volunteers interested in a prevention trial, so it may not represent all older adults. This reading is based on the abstract only.

Mise en perspective

The study fits the idea that regular, sufficient nighttime sleep may be good for the ageing brain, but the associations are small and cannot prove cause. It does not tell anyone to nap less or to sleep more to prevent Alzheimer disease. Persistent sleep problems or memory worries are worth discussing with a clinician.

Vos données

Wearables can show your nighttime sleep duration and any daytime naps, but they estimate sleep and cannot measure amyloid, so there is no brain-health score to read from them. Use the same device and compare weekly averages of nighttime sleep rather than single nights.

Comprendre ce type de preuve

Measurements are taken in the same period. Direction and causation usually cannot be determined; symptoms can change behaviour as well as the reverse.

Résumé structuré des auteurs English

Le résumé original en anglais est reproduit avec attribution sous la licence ouverte indiquée. Il s’agit d’une source, pas d’une interprétation MoveVitals. L’analyse préparée figure ci-dessus ; vérifiez les conclusions importantes dans la source.

Importance

Disrupted sleep commonly occurs with progressing neurodegenerative disease. Large, well-characterized neuroimaging studies of cognitively unimpaired adults are warranted to clarify the magnitude and onset of the association between sleep and emerging β-amyloid (Aβ) pathology.

Objective

To evaluate the associations between daytime and nighttime sleep duration with regional Aβ pathology in older cognitively unimpaired adults.

Design, setting, and participants

In this cross-sectional study, screening data were collected between April 1, 2014, and December 31, 2017, from healthy, cognitively unimpaired adults 65 to 85 years of age who underwent florbetapir F 18 positron emission tomography (PET), had APOE genotype information, scored between 25 and 30 on the Mini-Mental State Examination, and had a Clinical Dementia Rating of 0 for the Anti-Amyloid Treatment in Asymptomatic Alzheimer Disease (A4) Study. Data analysis was performed from December 1, 2019, to May 10, 2021.

Exposures

Self-reported daytime and nighttime sleep duration.

Main outcomes and measures

Regional Aβ pathology, measured by florbetapir PET standardized uptake value ratio.

Results

Amyloid PET and sleep duration information was acquired on 4425 cognitively unimpaired participants (mean [SD] age, 71.3 [4.7] years; 2628 [59.4%] female; 1509 [34.1%] tested Aβ positive). Each additional hour of nighttime sleep was associated with a 0.005 reduction of global Aβ standardized uptake value ratio (F1, 4419 = 5.0; P = .03), a 0.009 reduction of medial orbitofrontal Aβ (F1, 4419 = 17.4; P < .001), and a 0.011 reduction of anterior cingulate Aβ (F1, 4419 = 15.9; P < .001). When restricting analyses to participants who tested Aβ negative, nighttime sleep was associated with a 0.006 reduction of medial orbitofrontal Aβ (F1,2910 = 16.9; P < .001) and a 0.005 reduction of anterior cingulate Aβ (F1,2910 = 7.6; P = .03). Daytime sleep was associated with a 0.013 increase of precuneus Aβ (F1,2910 = 7.3; P = .03) and a 0.024 increase of posterior cingulate Aβ (F1,2910 = 14.2; P = .001) in participants who tested Aβ negative.

Conclusions and relevance

In this cross-sectional study, the increased risk of Aβ deposition with reduced nighttime sleep duration occurred early, before cognitive impairment or significant Aβ deposition. Daytime sleep may be associated with an increase in risk for early Aβ accumulation and did not appear to be corrective for loss of nighttime sleep, demonstrating a circadian rhythm dependence of sleep in preventing Aβ accumulation. Treatments that improve sleep may reduce early Aβ accumulation and aid in delaying the onset of cognitive dysfunction associated with early Alzheimer disease.

Sources et attribution

Association of Sleep and β-Amyloid Pathology Among Older Cognitively Unimpaired Adults.

Insel PS, Mohlenhoff BS, Neylan TC, Krystal AD, Mackin RS.

JAMA network open · 2021-07-01

DOI: 10.1001/jamanetworkopen.2021.17573 ↗PubMed · 34297074 ↗Europe PMC · Licence indiquée: cc by ↗

Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.

Interprétation éditoriale MoveVitals · contenu éducatif · aucune évaluation clinique individuelle enregistrée

Sources vérifiées 2026-11-01

Guides pratiques

À lire ensemble

·Méta-analyse d’essais

Exercise improved sleep-quality scores in adults 45 and older with sleep disorders

Pooling 23 randomized trials with 1,478 adults aged 45 to 77 who had sleep disorders, exercise improved Pittsburgh Sleep Quality Index scores (SMD 0.62, 95% CI 0.40–0.83), and aerobic exercise showed the largest effect in the network analysis (SMD 1.34, 95% CrI 0.86–1.82). Certainty was low to moderate, the outcomes were questionnaires, and the best weekly dose of about 539 MET-min/week is a model estimate, not a prescription.

Journal of Exercise Science & Fitness

Explications approfondiesLire l’étude →
·Étude de cohorte

Sleep regularity tracked mortality more closely than sleep duration in 60,977 UK adults

Among 60,977 UK Biobank adults who wore a wrist accelerometer for a week, the most regular fifth of sleepers had a fully adjusted all-cause mortality HR of 0.70 (95% CI 0.59–0.83) against the least regular fifth, over about 6.3 years and 1859 deaths. Regularity fitted the data better than sleep duration, but the study is observational and rests on one week of sleep data.

Sleep

Explications approfondiesLire l’étude →
·Essai randomisé

Sleep extension cut daily energy intake by about 270 kcal in adults with overweight

In 80 adults with overweight who usually slept under 6.5 hours, two weeks of sleep-extension counselling added about 1.2 hours of sleep and lowered measured energy intake by 270.4 kcal/d versus control (95% CI −393.4 to −147.4). The trial was short, single-centre and in a narrow group, so it does not show lasting weight loss or any benefit for people who already sleep enough.

JAMA Internal Medicine

Explications approfondiesLire l’étude →
·Étude de cohorte

Six hours or less of sleep at 50 and 60 linked to higher dementia risk

In 7959 British civil servants followed for about 25 years, sleeping six hours or less at age 50 (HR 1.22, 95% CI 1.01–1.48) or age 60 (HR 1.37, 1.10–1.72) was linked to a higher dementia rate than sleeping seven hours, and persistent short sleep gave an HR of 1.30 (1.00–1.69). Sleep was mostly self-reported and the study is observational, so early brain disease or other factors may explain part of the link.

Nature Communications

Explications approfondiesLire l’étude →
Sommeil et rythmes →